2.07 USD
↘ 0.09 (3.98%)LIVE (AS OF 12:28 PM EDT)
Regentis Biomaterials Ltd.
RGNTAMEX • USD
Market: OPEN
RGNT is currently priced at $2.07. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Aug 24, 2026.
Open?$2.10
High?$2.14
Low?$2.00
Prev. Close?$2.16
Volume?11.3K
Avg. Volume?N/A
VWAP?$2.07
Bid / Ask
Bid?$2.05 × 100
Ask?$2.10 × 100
Spread?$0.05
Midpoint?$2.08
Valuation & Ratios
Market Cap?14.8M
Shares Out?7.0M
Float?2.1M
Float %?40.6%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?1.77%Low
Short Interest?37.1K
Days to Cover?1.0
Free Float2.1M
Avg Daily Volume138.2K
Settlement Date2026-07-31